Extensive Pigment Incontinence Mimicking Persistent Melanoma After Talimogene Laherparepvec Therapy
Author:
Affiliation:
1. Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Publisher
American Medical Association (AMA)
Subject
Dermatology
Link
http:///jamadermatology/article-pdf/155/4/496/17478228/jamadermatology_danesh_2019_lo_180037.pdf
Reference5 articles.
1. Talimogene Laherparepvec for the Treatment of Advanced Melanoma.;Ott;Clin Cancer Res,2016
2. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma.;Andtbacka;J Clin Oncol,2015
3. Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial.;Harrington;Onco Targets Ther,2016
4. Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.;Senzer;J Clin Oncol,2009
5. Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases.;Everett;J Cutan Pathol,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments;Journal of the American Academy of Dermatology;2023-06
2. Tumoral melanosis mimicking residual melanoma in the setting of talimogene laherparepvec treatment;Journal for ImmunoTherapy of Cancer;2022-10
3. Talimogene laherparepvec pseudolymphomatous reaction mimicking metastatic melanoma;Journal of Cutaneous Pathology;2021-07-08
4. Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec;Melanoma Research;2020-04-22
5. Talimogene laherparepvec;Reactions Weekly;2019-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3